BioMarin Pharmaceutical, Inc. (BMRN)
56.32
+1.73
(+3.17%)
USD |
NASDAQ |
Jan 20, 16:00
56.30
-0.02
(-0.04%)
After-Hours: 20:00
BioMarin Pharmaceutical Free Cash Flow: 825.79M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics, Inc. | 9.691M |
| Gilead Sciences, Inc. | 9.162B |
| Merck & Co., Inc. | 13.05B |
| AbbVie, Inc. | 19.68B |
| Biogen, Inc. | 2.262B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 368.68M |
| Cash from Investing (Quarterly) | -330.96M |
| Cash from Financing (Quarterly) | -2.169M |
| Free Cash Flow Per Share (Quarterly) | 1.744 |
| Free Cash Flow to Equity (Quarterly) | 335.63M |
| Free Cash Flow to Firm (Quarterly) | 337.95M |
| Free Cash Flow Yield | 7.50% |